Our survival analysis revealed that BC patients expressing high levels of HS3ST3A1 and RAB23 had a poor prognosis (HS3ST3A1 p < 0.005, RAB23 p < 0.005, by log-rank test). The gene discussed is RAB23; the disease is breast cancer.